Skip to main content
RxCopaysGet started

Affordability Check

How to afford Omalizumab-igec

Pick how you're covered. We'll show you the cheapest legitimate way to get Omalizumab-igec — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.

How are you covered for prescriptions?

Pick the one that fits you. We'll show you the cheapest way to get this drug.

Pick an option above to see your specific path.

Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.

About Omalizumab-igec and its cost

Omalizumab is a prescription biologic medication known as a monoclonal antibody that targets immunoglobulin E, which is an antibody in the immune system that triggers allergic reactions. It is primarily used to treat patients with moderate to severe persistent asthma caused by year-round allergens when their symptoms are not properly managed with traditional inhaled corticosteroids. Beyond respiratory issues, it is also prescribed for adults to treat chronic rhinosinusitis with nasal polyps, helping to reduce the size of the polyps and improve symptoms like nasal congestion. This medication is also frequently used for the treatment of chronic spontaneous urticaria, a condition characterized by chronic hives that do not have an identifiable cause and fail to respond to standard antihistamine therapy. Furthermore, it has been approved for reducing the risk of severe allergic reactions, including anaphylaxis, in individuals with food allergies who may be accidentally exposed to certain allergens. The medication is typically administered through a subcutaneous injection every two or four weeks, depending on the specific condition and the patient's weight and initial immunoglobulin levels.

Omalizumab-igec is made by Genentech. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.

Common questions

What's the cheapest way to afford Omalizumab-igec?

It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.

Can I use a copay card with Medicare for Omalizumab-igec?

No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Genentech has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.

Does my Medicare Part D plan cover Omalizumab-igec?

Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.

How long does a Patient Assistance Program take?

Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.

What if I have a high-deductible plan?

For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.

Are there charity grants for Chronic Hives?

Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.

More about Omalizumab-igec